ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 57 filers reported holding ADC THERAPEUTICS SA in Q2 2023. The put-call ratio across all filers is 37.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,818,106 | -30.3% | 1,524,717 | -1.0% | 0.00% | 0.0% |
| Q1 2024 | $6,916,885 | +185.5% | 1,540,509 | +5.5% | 0.00% | – |
| Q4 2023 | $2,422,793 | +156.5% | 1,459,514 | +38.6% | 0.00% | – |
| Q3 2023 | $944,521 | -61.4% | 1,052,978 | -7.4% | 0.00% | -100.0% |
| Q2 2023 | $2,445,816 | -46.7% | 1,137,589 | -51.7% | 0.00% | 0.0% |
| Q1 2023 | $4,589,725 | -44.7% | 2,353,705 | +8.9% | 0.00% | -50.0% |
| Q4 2022 | $8,299,607 | +6014108.0% | 2,161,356 | +7442.7% | 0.00% | – |
| Q3 2022 | $138 | – | 28,655 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 11,167,800 | $24,010,770 | 3.60% |
| Sio Capital Management, LLC | 4,020,705 | $8,644,516 | 2.20% |
| Redmile Group, LLC | 14,049,935 | $30,207,360 | 1.16% |
| Vantage Consulting Group Inc | 885,520 | $1,903,868 | 1.10% |
| Blue Owl Capital Holdings LP | 733,568 | $1,577,171 | 0.97% |
| AlphaCentric Advisors LLC | 778,000 | $1,672,700 | 0.93% |
| Affinity Asset Advisors, LLC | 600,000 | $1,290,000 | 0.45% |
| GCM Grosvenor Holdings, LLC | 410,888 | $883,409 | 0.38% |
| Indie Asset Partners, LLC | 93,839 | $201,754 | 0.22% |
| Frazier Life Sciences Management, L.P. | 1,647,030 | $3,541,115 | 0.21% |